Value of high-output pace-mapping of the right phrenic nerve for enabling safe radiofrequency ablation of atrial fibrillation: insights from three-dimensional computed tomography segmentation
Europace · 2024
DOI: 10.1093/europace/euae207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Europace, 2024. Verfasst von Fabien Squara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Pasteur University Hospital, 30 avenue de la Voie Romaine, 06000 Nice, France. Hauptthemen laut MEDLINE: Phrenic Nerve, Atrial Fibrillation, Catheter Ablation, Imaging, Three-Dimensional. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Right phrenic nerve (RPN) injury is a disabling but uncommon complication of atrial fibrillation (AF) radiofrequency ablation. Pace-mapping is widely used to infer RPN’s course, for limiting the risk of palsy by avoiding ablation at capture sites. However, information is lacking regarding the distance between the endocardial sites of capture and the actual anatomic RPN location. We aimed at determining the distance between endocardial sites of capture and anatomic CT location of the RPN, depending on the capture threshold. Methods and results In consecutive patients undergoing AF radiofrequency ablation, we defined the course of the RPN on the electroanatomical map with high-output pacing at up to 50 mA/2 ms, and assessed RPN capture threshold (RPN-t). The true anatomic course of the RPN was delineated and segmented using CT scan, then merged with the electroanatomical map. The distance between pacing sites and the RPN was assessed. In 45 patients, 1033 pacing sites were analysed. Distances from pacing sites to RPN ranged from 7.5 ± 3.0 mm (min 1) when RPN-t was ≤10 mA to 19.2 ± 6.5 mm (min 9.4) in cases of non-capture at 50 mA. A distance to the phrenic nerve > 10 mm was predicted by RPN-t with a ROC curve area of 0.846 [0.821–0.870] (P < 0.001), with Se = 80.8% and Sp = 77.5% if RPN-t > 20 mA, Se = 68.0% and Sp = 91.6% if RPN-t > 30 mA, and Se = 42.4% and Sp = 97.6% if non-capture at 50 mA.
Conclusion
These data emphasize the utility of high-output pace-mapping of the RPN. Non-capture at 50 mA/2 ms demonstrated very high specificity for predicting a distance to the RPN > 10 mm, ensuring safe radiofrequency delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Pasteur University Hospital, 30 avenue de la Voie Romaine, 06000 Nice, France.
- Department of Cardiac Electrophysiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
- Department of Radiology, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA.
ORCID-Profile: Fabien Squara, Gregory Supple, Ioan Liuba, Michal Wasiak, Erica Zado, Benoit Desjardins, Francis E Marchlinski
Zitieren
APA
Squara, F., Supple, G., Liuba, I., Wasiak, M., Zado, E., Desjardins, B., & Marchlinski, F. E. (2024). Value of high-output pace-mapping of the right phrenic nerve for enabling safe radiofrequency ablation of atrial fibrillation: insights from three-dimensional computed tomography segmentation. Europace. https://doi.org/10.1093/europace/euae207
Vancouver
Squara F, Supple G, Liuba I, Wasiak M, Zado E, Desjardins B, et al. Value of high-output pace-mapping of the right phrenic nerve for enabling safe radiofrequency ablation of atrial fibrillation: insights from three-dimensional computed tomography segmentation. Europace. 2024. doi:10.1093/europace/euae207
BibTeX
@article{Squara2024,
author = {Squara, Fabien and Supple, Gregory and Liuba, Ioan and Wasiak, Michal and Zado, Erica and Desjardins, Benoit and Marchlinski, Francis E},
title = {Value of high-output pace-mapping of the right phrenic nerve for enabling safe radiofrequency ablation of atrial fibrillation: insights from three-dimensional computed tomography segmentation},
journal = {Europace},
year = {2024},
doi = {10.1093/europace/euae207}
}
EUVIMED